Yeriel Estrada Selected Research

Yeriel Estrada Research Topics

Disease

18	Atopic Dermatitis (Atopic Eczema) 10/2023 - 10/2015
9	Neoplasms (Cancer) 03/2023 - 06/2002
5	Melanoma (Melanoma, Malignant) 03/2023 - 02/2009
5	Inflammation (Inflammations) 01/2023 - 01/2019
5	Carcinoma (Carcinomatosis) 03/2013 - 06/2002
4	Neoplasm Metastasis (Metastasis) 03/2023 - 01/2012
4	Alopecia Areata 03/2023 - 11/2018
4	Atherosclerosis 10/2021 - 01/2017
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2017
3	Hyperplasia 01/2019 - 01/2018
2	Pruritus (Itching) 10/2023 - 01/2023
2	Hypersensitivity (Allergy) 06/2023 - 01/2020
2	Alopecia (Baldness) 03/2023 - 01/2022
2	Ichthyosis (Xeroderma) 01/2022 - 10/2018
2	Eczema 10/2021 - 01/2018
2	Skin Diseases (Skin Disease) 10/2021 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2015 - 01/2012
1	Wells syndrome 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Congenital Ichthyosiform Erythroderma 01/2022
1	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 01/2022
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2022
1	Netherton Syndrome 01/2022
1	Vitiligo 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2017
4	diphenylcyclopropenoneIBA 06/2023 - 12/2022
4	Interleukin-13IBA 01/2023 - 01/2019
4	dupilumabIBA 10/2021 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
3	CytokinesIBA 01/2022 - 01/2019
3	6-sulfo sialyl Lewis XIBA 01/2019 - 10/2015
3	Interleukin-22 (IL-22)IBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 03/2023 - 12/2022
2	SaltsIBA 03/2023 - 01/2022
2	ProteomeIBA 01/2023 - 01/2023
2	ChemokinesIBA 01/2023 - 01/2020
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 02/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2019
2	LipidsIBA 01/2021 - 01/2018
2	Immunoglobulin E (IgE)IBA 01/2020 - 01/2019
2	fezakinumabIBA 01/2019 - 01/2018
2	Filaggrin ProteinsIBA 01/2019 - 01/2018
2	loricrinIBA 01/2019 - 01/2018
2	Keratin-16 (Keratin 16)IBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2013
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2009 - 06/2002
1	difelikefalinIBA 10/2023
1	Opioid Receptors (Opioid Receptor)IBA 10/2023
1	HaptensIBA 06/2023
1	Immune Checkpoint ProteinsIBA 03/2023
1	delgocitinibIBA 03/2023
1	baricitinibIBA 01/2023
1	crisaboroleIBA 01/2023
1	pembrolizumabIBA 12/2022
1	Immunologic Factors (Immunomodulators)IBA 12/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	VaccinesIBA 01/2022
1	Tec protein-tyrosine kinaseIBA 01/2022
1	Janus KinasesIBA 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	InterleukinsIBA 10/2021
1	secukinumabIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2021
1	E-SelectinIBA 01/2020
1	chitotriosidaseIBA 01/2020
1	AntigensIBA 01/2020
1	Staphylococcal enterotoxin FIBA 01/2020
1	AntibodiesIBA 01/2020
1	S100A12 ProteinIBA 01/2020
1	AllergensIBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	ClaudinsIBA 01/2019
1	Liver X ReceptorsIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Sterol Regulatory Element Binding Protein 1IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Chemokine CX3CL1IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2015
1	Orphan Nuclear ReceptorsIBA 01/2015
1	trans-sodium crocetinate (crocetin)IBA 02/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2014

Therapy/Procedure

3	Therapeutics 10/2023 - 02/2009
2	Immunotherapy 03/2023 - 12/2022
1	Aftercare (After-Treatment) 01/2020